Kenneth V Janosko

Kenneth V. Janosko serves as a key procurement lead within the W6QK Acc-apg Natick office of the U.S. Army, supporting the Department of Defense’s mission to develop and field advanced soldier systems. He manages acquisitions for mission-critical pharmaceutical and medical preparation products essential to battlefield health, including flame-resistant medical countermeasures, life-sustaining battlefield pharmaceuticals, and specialized chemical/biological defense formulations. His work directly enables the Army’s Medical Research and Development Command to equip warfighters with scientifically validated, combat-ready medical solutions, ensuring operational readiness through timely, compliant contract execution. Janosko maintains consistent contracting relationships with EPERNAY DESIGN & CONSTRUCTION LLC and TEVET LLC, both of which provide specialized manufacturing, formulation, and technical support services for military-grade pharmaceutical preparations. These partnerships reflect a pattern of engagement with niche, high-compliance vendors capable of meeting stringent DoD quality standards, including cGMP, FDA alignment, and defense-specific supply chain security protocols. His procurement approach emphasizes technical rigor, regulatory adherence, and long-term vendor reliability over volume-driven sourcing. His acquisition portfolio shows a 100% focus on open, non-set-aside competitions, indicating a procurement strategy prioritizing technical capability and mission-critical performance over socioeconomic preferences. While small business participation is not formally targeted through set-asides, his contracting decisions are driven by the unique demands of pharmaceutical manufacturing in defense contexts, where only a limited pool of qualified vendors exists. Janosko’s primary NAICS focus is 325412 (Pharmaceutical Preparation Manufacturing), reflecting deep expertise in procuring sterile, stabilized, and combat-optimized pharmaceuticals. His acquisitions span injectables, topical countermeasures, and thermally stable formulations designed for extreme environmental conditions. His technical domain centers on the intersection of pharmacology, military medicine, and defense logistics, ensuring that every contract supports the Army’s goal of sustaining soldier survivability through science-driven medical innovation.